Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial

BACKGROUND: Non-clear cell renal cell carcinoma (nccRCC) is a blanket term for a collection of heterogeneous and biologically diverse RCC histologies, including but not limited to papillary, chromophobe, and unclassified subtypes. Tivozanib is a selective vascular endothelial growth factor receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Barata, Pedro C, Chehrazi-Raffle, Alexander, Allman, Kimberly D, Asnis-Alibozek, Aviva, Kasturi, Vijay, Pal, Sumanta K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546822/
https://www.ncbi.nlm.nih.gov/pubmed/37315114
http://dx.doi.org/10.1093/oncolo/oyad132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546822/
https://www.ncbi.nlm.nih.gov/pubmed/37315114
http://dx.doi.org/10.1093/oncolo/oyad132

Ejemplares similares